NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis

Nuclear factor erythroid-2 related factor 2 (NRF2) is a pivotal transcription factor that maintains cellular redox homeostasis and facilitates the development of malignant tumor phenotypes. At the molecular level, NRF2 promotes de novo serine synthesis and SUMOylation affects its function. Our resul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2019-12, Vol.466, p.39-48
Hauptverfasser: Guo, Haoyan, Xu, Jiaqian, Zheng, Quan, He, Jianli, Zhou, Wei, Wang, Kezhou, Huang, Xian, Fan, Qiuju, Ma, Jiao, Cheng, Jinke, Mei, Wenhan, Xing, Rong, Cai, Rong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 48
container_issue
container_start_page 39
container_title Cancer letters
container_volume 466
creator Guo, Haoyan
Xu, Jiaqian
Zheng, Quan
He, Jianli
Zhou, Wei
Wang, Kezhou
Huang, Xian
Fan, Qiuju
Ma, Jiao
Cheng, Jinke
Mei, Wenhan
Xing, Rong
Cai, Rong
description Nuclear factor erythroid-2 related factor 2 (NRF2) is a pivotal transcription factor that maintains cellular redox homeostasis and facilitates the development of malignant tumor phenotypes. At the molecular level, NRF2 promotes de novo serine synthesis and SUMOylation affects its function. Our results indicated that the SUMO1 acceptor site of NRF2 is the conserved lysine residue 110 (K110), and that NRF2 SUMOylation deficiency inhibited tumorigenesis in hepatocellular carcinoma (HCC). Mechanistically, NRF2 SUMOylation promoted de novo serine synthesis in HCC by enhancing the clearance of intracellular reactive oxygen species (ROS) and up-regulating phosphoglycerate dehydrogenase (PHGDH). More importantly, serine starvation increased the level of NRF2 SUMOylation, leading to sustained HCC growth. Collectively, our results indicate the presence of a novel NRF2 SUMOylation-mediated signaling process that maintains HCC tumorigenesis in normal conditions and in response to metabolic stress. •NRF2 is conjugated by SUMO1 at K110.•NRF2 SUMOylation maintains HCC tumorigenesis.•NRF2 SUMOylation promotes de novo serine synthesis in HCC via ROS-PHGDH signaling.•Serine starvation induces NRF2 SUMOylation.
doi_str_mv 10.1016/j.canlet.2019.09.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2296663956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383519304744</els_id><sourcerecordid>2296663956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-618857966be69d5a1f8776897be1bbcbe4a8dce85258e060780a4dbed1ec40d33</originalsourceid><addsrcrecordid>eNp9kFFrFDEQx4Mo7Vn7DUQCvviy5yS7m01eBDlaK9QWWvscssmc5thNapIt3Lc3x1UffBBmmIf85p_hR8hbBmsGTHzcra0JE5Y1B6bWUIvBC7JicuDNoCS8JCtooWta2fan5HXOOwDou6E_Iact6zsBvFuRu5u7S07vH77d7idTfAz0McU5FszUIQ3xKdKMyQekeR_KT8w-UxMcnY0PpXamV5sNLcsck_-B4fD-hrzaminj-fM8Iw-XF983V8317Zevm8_XjW0VlEYwKftBCTGiUK43bCuHQUg1jMjG0Y7YGeksyp73EkHAIMF0bkTH0Hbg2vaMfDjm1ot_LZiLnn22OE0mYFyy5ryGi1b1oqLv_0F3cUmhXqd5C6C4VAIq1R0pm2LOCbf6MfnZpL1moA_O9U4fneuDcw212GHt3XP4Ms7o_i79kVyBT0cAq40nj0ln6zFYdD6hLdpF__8ffgP2MpOH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2300928960</pqid></control><display><type>article</type><title>NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Guo, Haoyan ; Xu, Jiaqian ; Zheng, Quan ; He, Jianli ; Zhou, Wei ; Wang, Kezhou ; Huang, Xian ; Fan, Qiuju ; Ma, Jiao ; Cheng, Jinke ; Mei, Wenhan ; Xing, Rong ; Cai, Rong</creator><creatorcontrib>Guo, Haoyan ; Xu, Jiaqian ; Zheng, Quan ; He, Jianli ; Zhou, Wei ; Wang, Kezhou ; Huang, Xian ; Fan, Qiuju ; Ma, Jiao ; Cheng, Jinke ; Mei, Wenhan ; Xing, Rong ; Cai, Rong</creatorcontrib><description>Nuclear factor erythroid-2 related factor 2 (NRF2) is a pivotal transcription factor that maintains cellular redox homeostasis and facilitates the development of malignant tumor phenotypes. At the molecular level, NRF2 promotes de novo serine synthesis and SUMOylation affects its function. Our results indicated that the SUMO1 acceptor site of NRF2 is the conserved lysine residue 110 (K110), and that NRF2 SUMOylation deficiency inhibited tumorigenesis in hepatocellular carcinoma (HCC). Mechanistically, NRF2 SUMOylation promoted de novo serine synthesis in HCC by enhancing the clearance of intracellular reactive oxygen species (ROS) and up-regulating phosphoglycerate dehydrogenase (PHGDH). More importantly, serine starvation increased the level of NRF2 SUMOylation, leading to sustained HCC growth. Collectively, our results indicate the presence of a novel NRF2 SUMOylation-mediated signaling process that maintains HCC tumorigenesis in normal conditions and in response to metabolic stress. •NRF2 is conjugated by SUMO1 at K110.•NRF2 SUMOylation maintains HCC tumorigenesis.•NRF2 SUMOylation promotes de novo serine synthesis in HCC via ROS-PHGDH signaling.•Serine starvation induces NRF2 SUMOylation.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2019.09.010</identifier><identifier>PMID: 31546024</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Amino acids ; Animals ; Biosynthesis ; Cancer ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - pathology ; Cell growth ; Cell Line, Tumor ; Enzymes ; Experiments ; Female ; Hep G2 Cells ; Hepatocellular carcinoma ; Homeostasis ; Humans ; Kinases ; Liver cancer ; Liver Neoplasms - metabolism ; Liver Neoplasms - pathology ; Lysine ; Metabolism ; Mice ; Mutation ; Neoplasm Transplantation ; NF-E2-Related Factor 2 - chemistry ; NF-E2-Related Factor 2 - metabolism ; Nuclear factor erythroid-2 related factor 2 ; Oxidative Stress ; Penicillin ; Phenotypes ; Phosphoglycerate dehydrogenase ; Phosphoglycerate Dehydrogenase - metabolism ; Phosphorylation ; Plasmids ; Proteins ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Serine ; Serine - metabolism ; Serine synthesis ; Signal transduction ; Small ubiquitin-like protein ; Stress, Physiological ; SUMO protein ; Sumoylation ; Transcription factors ; Tumorigenesis</subject><ispartof>Cancer letters, 2019-12, Vol.466, p.39-48</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><rights>2019. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-618857966be69d5a1f8776897be1bbcbe4a8dce85258e060780a4dbed1ec40d33</citedby><cites>FETCH-LOGICAL-c390t-618857966be69d5a1f8776897be1bbcbe4a8dce85258e060780a4dbed1ec40d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.canlet.2019.09.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31546024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Haoyan</creatorcontrib><creatorcontrib>Xu, Jiaqian</creatorcontrib><creatorcontrib>Zheng, Quan</creatorcontrib><creatorcontrib>He, Jianli</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Wang, Kezhou</creatorcontrib><creatorcontrib>Huang, Xian</creatorcontrib><creatorcontrib>Fan, Qiuju</creatorcontrib><creatorcontrib>Ma, Jiao</creatorcontrib><creatorcontrib>Cheng, Jinke</creatorcontrib><creatorcontrib>Mei, Wenhan</creatorcontrib><creatorcontrib>Xing, Rong</creatorcontrib><creatorcontrib>Cai, Rong</creatorcontrib><title>NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Nuclear factor erythroid-2 related factor 2 (NRF2) is a pivotal transcription factor that maintains cellular redox homeostasis and facilitates the development of malignant tumor phenotypes. At the molecular level, NRF2 promotes de novo serine synthesis and SUMOylation affects its function. Our results indicated that the SUMO1 acceptor site of NRF2 is the conserved lysine residue 110 (K110), and that NRF2 SUMOylation deficiency inhibited tumorigenesis in hepatocellular carcinoma (HCC). Mechanistically, NRF2 SUMOylation promoted de novo serine synthesis in HCC by enhancing the clearance of intracellular reactive oxygen species (ROS) and up-regulating phosphoglycerate dehydrogenase (PHGDH). More importantly, serine starvation increased the level of NRF2 SUMOylation, leading to sustained HCC growth. Collectively, our results indicate the presence of a novel NRF2 SUMOylation-mediated signaling process that maintains HCC tumorigenesis in normal conditions and in response to metabolic stress. •NRF2 is conjugated by SUMO1 at K110.•NRF2 SUMOylation maintains HCC tumorigenesis.•NRF2 SUMOylation promotes de novo serine synthesis in HCC via ROS-PHGDH signaling.•Serine starvation induces NRF2 SUMOylation.</description><subject>Amino acids</subject><subject>Animals</subject><subject>Biosynthesis</subject><subject>Cancer</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Enzymes</subject><subject>Experiments</subject><subject>Female</subject><subject>Hep G2 Cells</subject><subject>Hepatocellular carcinoma</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - pathology</subject><subject>Lysine</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Mutation</subject><subject>Neoplasm Transplantation</subject><subject>NF-E2-Related Factor 2 - chemistry</subject><subject>NF-E2-Related Factor 2 - metabolism</subject><subject>Nuclear factor erythroid-2 related factor 2</subject><subject>Oxidative Stress</subject><subject>Penicillin</subject><subject>Phenotypes</subject><subject>Phosphoglycerate dehydrogenase</subject><subject>Phosphoglycerate Dehydrogenase - metabolism</subject><subject>Phosphorylation</subject><subject>Plasmids</subject><subject>Proteins</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Serine</subject><subject>Serine - metabolism</subject><subject>Serine synthesis</subject><subject>Signal transduction</subject><subject>Small ubiquitin-like protein</subject><subject>Stress, Physiological</subject><subject>SUMO protein</subject><subject>Sumoylation</subject><subject>Transcription factors</subject><subject>Tumorigenesis</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFFrFDEQx4Mo7Vn7DUQCvviy5yS7m01eBDlaK9QWWvscssmc5thNapIt3Lc3x1UffBBmmIf85p_hR8hbBmsGTHzcra0JE5Y1B6bWUIvBC7JicuDNoCS8JCtooWta2fan5HXOOwDou6E_Iact6zsBvFuRu5u7S07vH77d7idTfAz0McU5FszUIQ3xKdKMyQekeR_KT8w-UxMcnY0PpXamV5sNLcsck_-B4fD-hrzaminj-fM8Iw-XF983V8317Zevm8_XjW0VlEYwKftBCTGiUK43bCuHQUg1jMjG0Y7YGeksyp73EkHAIMF0bkTH0Hbg2vaMfDjm1ot_LZiLnn22OE0mYFyy5ryGi1b1oqLv_0F3cUmhXqd5C6C4VAIq1R0pm2LOCbf6MfnZpL1moA_O9U4fneuDcw212GHt3XP4Ms7o_i79kVyBT0cAq40nj0ln6zFYdD6hLdpF__8ffgP2MpOH</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Guo, Haoyan</creator><creator>Xu, Jiaqian</creator><creator>Zheng, Quan</creator><creator>He, Jianli</creator><creator>Zhou, Wei</creator><creator>Wang, Kezhou</creator><creator>Huang, Xian</creator><creator>Fan, Qiuju</creator><creator>Ma, Jiao</creator><creator>Cheng, Jinke</creator><creator>Mei, Wenhan</creator><creator>Xing, Rong</creator><creator>Cai, Rong</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20191201</creationdate><title>NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis</title><author>Guo, Haoyan ; Xu, Jiaqian ; Zheng, Quan ; He, Jianli ; Zhou, Wei ; Wang, Kezhou ; Huang, Xian ; Fan, Qiuju ; Ma, Jiao ; Cheng, Jinke ; Mei, Wenhan ; Xing, Rong ; Cai, Rong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-618857966be69d5a1f8776897be1bbcbe4a8dce85258e060780a4dbed1ec40d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Amino acids</topic><topic>Animals</topic><topic>Biosynthesis</topic><topic>Cancer</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Enzymes</topic><topic>Experiments</topic><topic>Female</topic><topic>Hep G2 Cells</topic><topic>Hepatocellular carcinoma</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - pathology</topic><topic>Lysine</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Mutation</topic><topic>Neoplasm Transplantation</topic><topic>NF-E2-Related Factor 2 - chemistry</topic><topic>NF-E2-Related Factor 2 - metabolism</topic><topic>Nuclear factor erythroid-2 related factor 2</topic><topic>Oxidative Stress</topic><topic>Penicillin</topic><topic>Phenotypes</topic><topic>Phosphoglycerate dehydrogenase</topic><topic>Phosphoglycerate Dehydrogenase - metabolism</topic><topic>Phosphorylation</topic><topic>Plasmids</topic><topic>Proteins</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Serine</topic><topic>Serine - metabolism</topic><topic>Serine synthesis</topic><topic>Signal transduction</topic><topic>Small ubiquitin-like protein</topic><topic>Stress, Physiological</topic><topic>SUMO protein</topic><topic>Sumoylation</topic><topic>Transcription factors</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Haoyan</creatorcontrib><creatorcontrib>Xu, Jiaqian</creatorcontrib><creatorcontrib>Zheng, Quan</creatorcontrib><creatorcontrib>He, Jianli</creatorcontrib><creatorcontrib>Zhou, Wei</creatorcontrib><creatorcontrib>Wang, Kezhou</creatorcontrib><creatorcontrib>Huang, Xian</creatorcontrib><creatorcontrib>Fan, Qiuju</creatorcontrib><creatorcontrib>Ma, Jiao</creatorcontrib><creatorcontrib>Cheng, Jinke</creatorcontrib><creatorcontrib>Mei, Wenhan</creatorcontrib><creatorcontrib>Xing, Rong</creatorcontrib><creatorcontrib>Cai, Rong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Haoyan</au><au>Xu, Jiaqian</au><au>Zheng, Quan</au><au>He, Jianli</au><au>Zhou, Wei</au><au>Wang, Kezhou</au><au>Huang, Xian</au><au>Fan, Qiuju</au><au>Ma, Jiao</au><au>Cheng, Jinke</au><au>Mei, Wenhan</au><au>Xing, Rong</au><au>Cai, Rong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>466</volume><spage>39</spage><epage>48</epage><pages>39-48</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Nuclear factor erythroid-2 related factor 2 (NRF2) is a pivotal transcription factor that maintains cellular redox homeostasis and facilitates the development of malignant tumor phenotypes. At the molecular level, NRF2 promotes de novo serine synthesis and SUMOylation affects its function. Our results indicated that the SUMO1 acceptor site of NRF2 is the conserved lysine residue 110 (K110), and that NRF2 SUMOylation deficiency inhibited tumorigenesis in hepatocellular carcinoma (HCC). Mechanistically, NRF2 SUMOylation promoted de novo serine synthesis in HCC by enhancing the clearance of intracellular reactive oxygen species (ROS) and up-regulating phosphoglycerate dehydrogenase (PHGDH). More importantly, serine starvation increased the level of NRF2 SUMOylation, leading to sustained HCC growth. Collectively, our results indicate the presence of a novel NRF2 SUMOylation-mediated signaling process that maintains HCC tumorigenesis in normal conditions and in response to metabolic stress. •NRF2 is conjugated by SUMO1 at K110.•NRF2 SUMOylation maintains HCC tumorigenesis.•NRF2 SUMOylation promotes de novo serine synthesis in HCC via ROS-PHGDH signaling.•Serine starvation induces NRF2 SUMOylation.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31546024</pmid><doi>10.1016/j.canlet.2019.09.010</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2019-12, Vol.466, p.39-48
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_2296663956
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Amino acids
Animals
Biosynthesis
Cancer
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Cell growth
Cell Line, Tumor
Enzymes
Experiments
Female
Hep G2 Cells
Hepatocellular carcinoma
Homeostasis
Humans
Kinases
Liver cancer
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Lysine
Metabolism
Mice
Mutation
Neoplasm Transplantation
NF-E2-Related Factor 2 - chemistry
NF-E2-Related Factor 2 - metabolism
Nuclear factor erythroid-2 related factor 2
Oxidative Stress
Penicillin
Phenotypes
Phosphoglycerate dehydrogenase
Phosphoglycerate Dehydrogenase - metabolism
Phosphorylation
Plasmids
Proteins
Reactive oxygen species
Reactive Oxygen Species - metabolism
Serine
Serine - metabolism
Serine synthesis
Signal transduction
Small ubiquitin-like protein
Stress, Physiological
SUMO protein
Sumoylation
Transcription factors
Tumorigenesis
title NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T15%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NRF2%20SUMOylation%20promotes%20de%20novo%20serine%20synthesis%20and%20maintains%20HCC%20tumorigenesis&rft.jtitle=Cancer%20letters&rft.au=Guo,%20Haoyan&rft.date=2019-12-01&rft.volume=466&rft.spage=39&rft.epage=48&rft.pages=39-48&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2019.09.010&rft_dat=%3Cproquest_cross%3E2296663956%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2300928960&rft_id=info:pmid/31546024&rft_els_id=S0304383519304744&rfr_iscdi=true